What people are saying.
August 16, 2016
Arno Completes $2.8 Million Private Placement
July 27, 2016
Kite Pharma Announces Exclusive License with the National Institutes of Health for Fully Human Anti-CD19 Chimeric Antigen Receptor (CAR) Product Candidate to Treat B-Cell Malignancies